Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

35.90USD
15 Oct 2018
Change (% chg)

$-1.80 (-4.77%)
Prev Close
$37.70
Open
$37.77
Day's High
$38.00
Day's Low
$34.69
Volume
388,373
Avg. Vol
318,803
52-wk High
$73.90
52-wk Low
$16.52

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.76 December 16 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 0 0 0
(2) OUTPERFORM 6 6 6 6
(3) HOLD 3 2 2 2
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.36 2.25 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7 3.33 11.30 0.50 7.80
Quarter Ending Mar-19 5 2.70 5.00 0.00 --
Year Ending Dec-18 8 7.95 24.00 2.90 13.93
Year Ending Dec-19 9 19.24 91.10 0.00 31.10
Earnings (per share)
Quarter Ending Dec-18 9 -0.76 -0.55 -0.92 -1.06
Quarter Ending Mar-19 5 -0.81 -0.74 -0.86 --
Year Ending Dec-18 9 -2.93 -2.58 -3.21 -3.02
Year Ending Dec-19 10 -3.19 -1.87 -4.31 -3.06

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 1.83 1.09 0.74 40.38
Quarter Ending Mar-18 2.51 1.36 1.15 45.92
Quarter Ending Dec-17 3.37 32.33 28.95 858.35
Quarter Ending Sep-17 3.06 2.39 0.67 21.87
Quarter Ending Jun-17 2.13 3.58 1.45 68.35
Earnings (per share)
Quarter Ending Jun-18 -0.63 -0.82 0.19 -30.06
Quarter Ending Mar-18 -0.67 -0.62 0.05 -7.48
Quarter Ending Dec-17 -0.67 0.00 0.67 -100.00
Quarter Ending Sep-17 -0.60 -0.62 0.02 -3.23
Quarter Ending Jun-17 -0.62 -0.56 0.06 -9.31

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3.33 3.96 4.45 4.32 7.80
Quarter Ending Mar-19 2.70 2.00 2.00 2.00 --
Year Ending Dec-18 7.95 8.79 9.10 9.55 13.93
Year Ending Dec-19 19.24 19.74 21.70 21.70 31.10
Earnings (per share)
Quarter Ending Dec-18 -0.76 -0.76 -0.77 -0.75 -1.06
Quarter Ending Mar-19 -0.81 -0.80 -0.87 -0.87 --
Year Ending Dec-18 -2.93 -2.92 -2.96 -2.87 -3.02
Year Ending Dec-19 -3.19 -3.15 -3.19 -3.17 -3.06

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 2 1 1
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Dec-18 0 0 1 0
Quarter Ending Mar-19 0 0 1 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 1 0